Press Release

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023.

King of Prussia, PA – August 9, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, is proud to announce its RBQMLive event has won Best Product in the experiential/event marketing category of this year’s Sales and Marketing Technology Awards (Sammys). The Business Intelligence Group’s prestigious awards program is designed to recognize those organizations working to solve the challenges of connecting and collaborating with prospects and customers.

RBQMLive is an annual event that brings together RBQM experts, clinical trial specialists, and curious listeners to discuss the adoption, utilization, and best practices of risk-based quality management (RBQM), a system for managing data quality throughout a clinical trial across the pharmaceutical sector. Sponsored and organized by CluePoints, the event takes place online over two days and is free to attend.

Launched following the height of the COVID-19 pandemic in 2021, when travel restrictions where still in place, RBQMLive is a purely educational platform. Each year, the event offers talks from some of the field’s leading minds, all designed to fill educational gaps, illuminate trending topics, provide fresh perspectives, and, ultimately, accelerate the adoption of the transformative approach to clinical trial conduct.

Patrick Hughes, Co-Founder, and Chief Commercial Officer of CluePoints, said: “We are delighted to have been recognized by the Business Intelligence Group for our work on RBQMLive and are proud to be in the esteemed company of our fellow Sammys winners. I would like to thank all the CluePoints staff who have worked so hard on making the event a success and a connection point amongst industry peers, which attracted more than 2,000 registered delegates last year. I would also like to thank the commitment of the industry thought leaders who presented at RBQMLive, as without their invaluable knowledge this event wouldn’t have been a success.

“RBQM is a relatively new study management approach. As the first company to bring the technology to the market, we feel we are responsible for educating the industry on its value, implementation, and regulatory basis. RBQMLive gives research and pharma professionals from all levels and functions access to some of the top minds in our field in a free, online format that meets the needs of modern professional education. In doing so it paves the path for our industry at large.”

“We are proud to reward and recognize RBQMLive for their innovation and dedication to helping both the organization using their technology and the ultimate consumer,” said Maria Jimenez, Chief Nominations Officer of Business Intelligence Group. “It was clear to our judges that their efforts will improve how we connect with the brands we love for years to come.”

For more information on, and to register for RBQMLive 2023, visit

About CluePoints

CluePoints is the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software. Our products utilize comprehensive statistical algorithms to determine clinical trial data quality, accuracy, and integrity, both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints® is deployed to support central and on-site monitoring, medical review, quality risk management, and drive a holistic risk-based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls, and solution implementation, you now have everything you need to adhere to global regulatory guidance. The result is increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBx.

About Business Intelligence Group

The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, business executives—those with experience and knowledge—judge the programs. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.


Media Contact

Jodie Dixon – Discovery PR, on behalf of CluePoints
Email:   [email protected]
Mobile:   +44 (0)7507 727721
Office:   +44 (0) 1606 889 194

Press Release
CluePoints, a Leading Provider of AI-Driven Software Solutions for Clinical Data Review, Receives Significant Investment for Continued Growth from EQT
Press Release
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’
Press Release
FDA And CluePoints Sign New 3 Year Cooperative Research And Development Agreement To Assess Data Quality Using Statistical Modelling And Machine Learning